Earnings Per Share

HALO Upcoming Earnings (Q4 2024)

Earnings Date: Feb 18, 2025
Consensus EPS: Premium

Current P/E ratio : 15.71
Price (Dec 04, 2024, EOD): $48.61

The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.

Last 3 Quarters for HALO Premium

Below you can see how HALO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo

FAQ

When is the earnings report for HALO?
Halozyme Therapeutics (HALO) has scheduled its earnings report for Feb 18, 2025 after the markets close.

What is the HALO price-to-earnings (P/E) ratio?
HALO P/E ratio as of Dec 04, 2024 (TTM) is 15.70.

What is the HALO EPS forecast?
The forecasted EPS (Earnings Per Share) for Halozyme Therapeutics (HALO) for the first fiscal quarter 2024 is $1.17.

What are Halozyme Therapeutics's retained earnings?
On its balance sheet, Halozyme Therapeutics reported retained earnings of $290.08 million for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
OXLC
$5.25
0.95% Dec 02
G
GOF
$15.83
0.569% Dec 02
QSR
$69.61
2.13% Nov 29
HP
$34.63
1.27% Nov 29
B
BSCO
$21.11
0.118% Nov 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE